Philip A. Hipskind

Person

Indianapolis, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
MET antibody drug conjugates
- Patent number 11,167,039
- Issue date Nov 9, 2021
- Eli Lilly and Company
- Yiqing Feng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Notch pathway signaling inhibitor compounds
- Patent number 10,450,317
- Issue date Oct 22, 2019
- Eli Lilly and Company
- Julia Marie Clay
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RAF inhibitor compounds
- Patent number 9,334,267
- Issue date May 10, 2016
- Deciphera Pharmaceuticals, LLC
- Daniel L. Flynn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Raf inhibitor compounds
- Patent number 9,187,474
- Issue date Nov 17, 2015
- Deciphera Pharmaceuticals, LLC
- Daniel L. Flynn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Disubstituted phthalazine hedgehog pathway antagonists
- Patent number 9,000,023
- Issue date Apr 7, 2015
- Eli Lilly and Company
- Philip Arthur Hipskind
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glucagon receptor antagonists, preparation and therapeutic uses
- Patent number 8,691,856
- Issue date Apr 8, 2014
- Eli Lilly and Company
- Scott Eugene Conner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Notch pathway signaling inhibitor compound
- Patent number 8,569,286
- Issue date Oct 29, 2013
- Eli Lilly and Company
- Philip Arthur Hipskind
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrasubstituted pyridazine hedgehog pathway antagonists
- Patent number 8,507,490
- Issue date Aug 13, 2013
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrasubstituted pyridazines hedgehog pathway antagonists
- Patent number 8,445,493
- Issue date May 21, 2013
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Disubstituted phthalazine hedgehog pathway antagonists
- Patent number 8,404,687
- Issue date Mar 26, 2013
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Disubstituted phthalazine hedgehog pathway antagonists
- Patent number 8,273,742
- Issue date Sep 25, 2012
- Eli Lilly and Company
- Philip Arthur Hipskind
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Histamine H3 receptor agents, preparation and therapeutic uses
- Patent number 8,178,528
- Issue date May 15, 2012
- Eli Lilly and Company
- Philip Arthur Hipskind
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glucagon receptor antagonists, preparation and therapeutic uses
- Patent number 8,076,374
- Issue date Dec 13, 2011
- Eli Lilly and Company
- Mark Donald Chappell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiazole pyrazolopyrimidines CRF1 receptor antagonists
- Patent number 8,030,304
- Issue date Oct 4, 2011
- Eli Lilly and Company
- Zhaogen Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Histamine H3 receptor agents, preparation and therapeutic uses
- Patent number 8,008,296
- Issue date Aug 30, 2011
- Eli Lilly and Company
- Lisa Selsam Beavers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Histamine H3 receptor agents, preparation and therapeutic uses
- Patent number 8,008,301
- Issue date Aug 30, 2011
- Eli Lilly and Company
- Lisa Selsam Beavers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Disubstituted phthalazine hedgehog pathway antagonists
- Patent number 7,981,892
- Issue date Jul 19, 2011
- Eli Lilly and Company
- Philip Arthur Hipskind
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolidine derivatives as histamine H3 receptor antagonists
- Patent number 7,951,826
- Issue date May 31, 2011
- Eli Lilly and Company
- Lisa Selsam Beavers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Histamine H3 receptor antagonists, preparation and therapeutic uses
- Patent number 7,902,191
- Issue date Mar 8, 2011
- Eli Lilly and Company
- Lisa Selsam Beavers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted thiophene carboxylic amide glucagon receptor antagonist...
- Patent number 7,807,702
- Issue date Oct 5, 2010
- Eli Lilly and Company
- Mark Donald Chappell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Histamine H3 receptor agents, preparation and therapeutic uses
- Patent number 7,705,025
- Issue date Apr 27, 2010
- Eli Lilly and Company
- Don Richard Finley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyridazine compounds
- Patent number 7,612,067
- Issue date Nov 3, 2009
- Eli Lilly and Company
- Heather Janelle Barbosa
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyridazine compounds
- Patent number 7,557,103
- Issue date Jul 7, 2009
- Eli Lilly and Company
- Elizabeth Aaron Collins
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Non-imidazole aryl alkylamines compounds as histamine H3 receptor a...
- Patent number 7,314,937
- Issue date Jan 1, 2008
- Eli Lilly and Company
- Lisa Selsam Beavers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiophene-and thiazolesulfonamides as antineoplastic agents
- Patent number 7,250,430
- Issue date Jul 31, 2007
- Eli Lilly and Company
- Cora Sue Grossman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multicyclic compounds for use as melanin concentrating hormone anta...
- Patent number 7,229,987
- Issue date Jun 12, 2007
- Eli Lilly and Company
- Jochen Ammenn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour...
- Patent number 7,183,320
- Issue date Feb 27, 2007
- Eli Lilly and Company
- Chuan Shih
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thiophene-amd thiazolesulfonamides as antineoplastic agents
- Patent number 7,084,170
- Issue date Aug 1, 2006
- Eli Lilly and Company
- Cora Sue Grossman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Non-peptide tachykinin receptor antagonists
- Patent number 6,869,957
- Issue date Mar 22, 2005
- Eli Lilly and Company
- Sung Y. Cho
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidinyl and piperazinyl tachykinin receptor antagonists
- Patent number 6,727,255
- Issue date Apr 27, 2004
- Eli Lilly and Company
- Sung Y. Cho
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
MET ANTIBODY DRUG CONJUGATES
- Publication number 20200061204
- Publication date Feb 27, 2020
- Eli Lilly and Company
- Yiqing FENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOTCH PATHWAY SIGNALING INHIBITOR COMPOUNDS
- Publication number 20180148456
- Publication date May 31, 2018
- Eli Lilly and Company
- Julia Marie Clay
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RAF INHIBITOR COMPOUNDS
- Publication number 20150119392
- Publication date Apr 30, 2015
- Deciphera Pharmaceuticals, LLC
- Daniel L. Flynn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RAF INHIBITOR COMPOUNDS
- Publication number 20150105367
- Publication date Apr 16, 2015
- Deciphera Pharmaceuticals, LLC
- Daniel L. Flynn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOTCH PATHWAY SIGNALING INHIBITOR COMPOUND
- Publication number 20130029972
- Publication date Jan 31, 2013
- Eli Lilly and Company
- Philip Arthur HIPSKIND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS
- Publication number 20120316174
- Publication date Dec 13, 2012
- Eli Lilly and Company
- Philip Arthur Hipskind
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRASUBSTITUTED PYRIDAZINE HEDGEHOG PATHWAY ANTAGONISTS
- Publication number 20110263602
- Publication date Oct 27, 2011
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS
- Publication number 20110190304
- Publication date Aug 4, 2011
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRASUBSTITUTED PYRIDAZINES HEDGEHOG PATHWAY ANTAGONISTS
- Publication number 20110178093
- Publication date Jul 21, 2011
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS
- Publication number 20110046143
- Publication date Feb 24, 2011
- Eli Lilly and Company
- Philip Arthur Hipskind
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS
- Publication number 20100324048
- Publication date Dec 23, 2010
- Eli Lilly and Company
- Philip Arthur Hipskind
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thiazole pyrazolopyrimidines CRF1 receptor antagonists
- Publication number 20100222339
- Publication date Sep 2, 2010
- Zhaogen Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES
- Publication number 20100160406
- Publication date Jun 24, 2010
- Philip Arthur Hipskind
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES
- Publication number 20100160319
- Publication date Jun 24, 2010
- Lisa Selsam Beavers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES
- Publication number 20100048580
- Publication date Feb 25, 2010
- Lisa Selsam Beavers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Histamine H3 Receptor Agents, Preparation and Therapeutic Uses
- Publication number 20100029608
- Publication date Feb 4, 2010
- Don Richard Finley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIOPHENE PYRAZOLOPYRIMIDINE COMPOUNDS
- Publication number 20100022560
- Publication date Jan 28, 2010
- Zhaogen Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES
- Publication number 20090156655
- Publication date Jun 18, 2009
- Scott Eugene Conner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES
- Publication number 20090048225
- Publication date Feb 19, 2009
- Don Richard Finley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
- Publication number 20080319074
- Publication date Dec 25, 2008
- Mark Donald Chappell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
- Publication number 20080300289
- Publication date Dec 4, 2008
- Mark Donald Chappell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrrolidine Derivatives as Histamine H3 Receptor Antagonists
- Publication number 20080207732
- Publication date Aug 28, 2008
- Lisa Selsam Beavers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Imidazopyridazine Compounds
- Publication number 20080153828
- Publication date Jun 26, 2008
- Elizabeth Aaron Collins
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Imidazopyridazine Compounds
- Publication number 20080113978
- Publication date May 15, 2008
- Heather Janelle Barbosa
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES
- Publication number 20070208024
- Publication date Sep 6, 2007
- Lisa Selsam Beavers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Histamine h3 receptor antagonists, preparation and therapeutic uses
- Publication number 20070155754
- Publication date Jul 5, 2007
- Lisa Selsam Beavers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thiophene-and thiazolesulfonamides as antineoplastic agents
- Publication number 20060223871
- Publication date Oct 5, 2006
- Cora Sue Grossman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Histamine h3 receptor antagonists, preparation and therapeutic uses
- Publication number 20060167046
- Publication date Jul 27, 2006
- Eli Lilly and Company Patent Division
- Lisa Selsam Beavers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tachykinin receptor antagonists
- Publication number 20060160794
- Publication date Jul 20, 2006
- Albert Kudzovi Amegadzie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted azepines as histamine h3 receptor antagonists, preparat...
- Publication number 20060089347
- Publication date Apr 27, 2006
- Eli Lilly and Company
- Robert Alan Gadski
- C07 - ORGANIC CHEMISTRY

Philip A. Hipskind

Person

Patents Grantslast 30 patents

MET antibody drug conjugates

Notch pathway signaling inhibitor compounds

RAF inhibitor compounds

Raf inhibitor compounds

Disubstituted phthalazine hedgehog pathway antagonists

Glucagon receptor antagonists, preparation and therapeutic uses

Notch pathway signaling inhibitor compound

Tetrasubstituted pyridazine hedgehog pathway antagonists

Tetrasubstituted pyridazines hedgehog pathway antagonists

Disubstituted phthalazine hedgehog pathway antagonists

Disubstituted phthalazine hedgehog pathway antagonists

Histamine H3 receptor agents, preparation and therapeutic uses

Glucagon receptor antagonists, preparation and therapeutic uses

Thiazole pyrazolopyrimidines CRF1 receptor antagonists

Histamine H3 receptor agents, preparation and therapeutic uses

Histamine H3 receptor agents, preparation and therapeutic uses

Disubstituted phthalazine hedgehog pathway antagonists

Pyrrolidine derivatives as histamine H3 receptor antagonists

Histamine H3 receptor antagonists, preparation and therapeutic uses

Substituted thiophene carboxylic amide glucagon receptor antagonist...

Histamine H3 receptor agents, preparation and therapeutic uses

Imidazopyridazine compounds

Imidazopyridazine compounds

Non-imidazole aryl alkylamines compounds as histamine H3 receptor a...

Thiophene-and thiazolesulfonamides as antineoplastic agents

Multicyclic compounds for use as melanin concentrating hormone anta...

Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour...

Thiophene-amd thiazolesulfonamides as antineoplastic agents

Non-peptide tachykinin receptor antagonists

Piperidinyl and piperazinyl tachykinin receptor antagonists

Patents Applicationslast 30 patents

MET ANTIBODY DRUG CONJUGATES

NOTCH PATHWAY SIGNALING INHIBITOR COMPOUNDS

RAF INHIBITOR COMPOUNDS

RAF INHIBITOR COMPOUNDS

NOTCH PATHWAY SIGNALING INHIBITOR COMPOUND

DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS

TETRASUBSTITUTED PYRIDAZINE HEDGEHOG PATHWAY ANTAGONISTS

DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS

TETRASUBSTITUTED PYRIDAZINES HEDGEHOG PATHWAY ANTAGONISTS

DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS

DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS

Thiazole pyrazolopyrimidines CRF1 receptor antagonists

HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES

HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES

HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES

Histamine H3 Receptor Agents, Preparation and Therapeutic Uses

THIOPHENE PYRAZOLOPYRIMIDINE COMPOUNDS

GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES

HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES

Glucagon Receptor Antagonists, Preparation and Therapeutic Uses

Glucagon Receptor Antagonists, Preparation and Therapeutic Uses

Pyrrolidine Derivatives as Histamine H3 Receptor Antagonists

Imidazopyridazine Compounds

Imidazopyridazine Compounds

HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES

Histamine h3 receptor antagonists, preparation and therapeutic uses

Thiophene-and thiazolesulfonamides as antineoplastic agents

Histamine h3 receptor antagonists, preparation and therapeutic uses

Tachykinin receptor antagonists

Substituted azepines as histamine h3 receptor antagonists, preparat...